Pfizer Q2 profit up 6.6% to ₹204 cr, CFO gap lingers
Revenue rose 8.3% to ₹653 cr, with no exceptional charges lifting net profit. But the board meeting came a day after the CFO resigned, leaving a leadership hole.
— 1 earlier story on Pfizer Ltd. →What's new
- Revenue of ₹653 cr, up 8.3% YoY.
- Net profit of ₹204 cr, up 6.6% YoY.
- No exceptional items this quarter versus ₹49 cr last year.
- Results approved a day after CFO Amit Agarwal resigned.
Why this matters
Pfizer delivered a clean quarter with steady growth and a debt-free balance sheet. But the sudden CFO exit with no successor named shifts attention to transition risk. The open question is who manages the next quarter's numbers.
What we're watching
- Timeline for a new CFO appointment.
- Whether operating margins stay above 39% in coming quarters.
- Any impact from the end of the Cipla brand distribution exceptional.
The full read
Pfizer's June quarter is a picture of steady execution. Revenue climbed 8.3% to ₹653.17 crore, net profit rose 6.6% to ₹204.47 crore, and for the first time in two years there were no exceptional items weighing on the bottom line. Operating margins held at ~39.6% — healthy by any measure. The balance sheet remains debt-free with ample cash. But the quarter's real news came a day before the earnings: CFO Amit Agarwal resigned, and no replacement is in place yet. For a company that relies on stable financial stewardship, the leadership gap is the one number the P&L doesn't capture. The growth is real, but the open question is who manages the next quarter's numbers.
Questions answered
- How did Pfizer's revenue and profit perform in Q2?
- Revenue was ₹653.17 crore, up 8.3% year-on-year. Net profit was ₹204.47 crore, up 6.6% from ₹191.75 crore a year earlier.
- Why were there no exceptional items this quarter?
- The prior year had exceptional charges of ₹49.16 crore related to the Cipla brand distribution deal and labour code provisions. Those costs did not recur in Q2.
- What is the status of the CFO position?
- CFO Amit Agarwal resigned on July 27, 2026, a day before the board approved the Q2 results. No successor has been named.
- What are Pfizer's operating margins?
- Operating margins for the quarter were around 39.6%, reflecting steady profitability.
- Is Pfizer carrying any debt?
- No. The company has a debt-free balance sheet and strong cash position, supporting dividends and operations.
Pfizer Ltd.
Latest quarter · Mar 2026
Strength & growth
Story so far
All notes on PFIZER →- 28 Jul 2026 · 1:57 PM IST Pfizer Q2 profit up 6.6% to ₹204 cr, CFO gap lingers
- 1d ago Pfizer loses CFO Amit Agarwal; no successor named